Application form: tablets, capsules
Indication group: antitussives
Active substance: Butamirati dihydrogenocitras 50 mg
minimum amount for dispatch: Sinecod : Butamirate citrate, the only active component of Sinecod 50 mg, has an effect on the central nervous system, in which it inhibits the cough reflex. It is not related to alkaloids (for ex. codeine). In addition to its ability to directly inhibit cough, it has a tendency to relieve resistance put up by the airways to air flowing through them while breathing and thus facilitates breathing. One tablets with a long-lasting release contains 93 mg of lactose and the use can be considered harmless for diabetics.
Manufacturer: Novartis s.r.o., Prague, Czech Republic, www.novartis.com
|SUKL název||SINECOD 50MG TBL PRO 10|